Mycophenolate Mofetil 250 mg/1

Mycophenolate mofetil 250 mg capsules are an immunosuppressant medication used to prevent organ rejection after transplants. This oral medication is manufactured by Accord Healthcare Inc. in the USA.

Mycophenolate mofetil is primarily used to prevent rejection of transplanted organs, such as kidneys, hearts, or livers. It works by suppressing the immune system to reduce the risk of the body attacking the new organ. This medication is often prescribed as part of a broader treatment plan following transplant surgery.

Common effects of mycophenolate mofetil may include nausea, vomiting, diarrhea, and abdominal pain. Some individuals might experience fatigue, fever, or an increased risk of infections due to the immunosuppressant nature of the drug. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Mycophenolate mofetil should be handled with care, as it can increase the risk of infections and other complications. It is essential to follow the prescribed dosage and administration instructions closely. Regular blood tests may be required to monitor the body's response to the medication. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider.

Mycophenolate mofetil may interact with other medications, including certain antibiotics, antivirals, and immunosuppressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect the immune system should be used with caution while taking this medication.